https://www.selleckchem.com/pr....oducts/acetosyringon
Our clinical case suggests that despite similar pharmacodynamic properties, quinapril and ramipril do not have the same potential to generate angioedema. To explain this difference, we suggest a potentiation of the effect of bradykinin at the B2 receptor level by ramipril, which does not occur with quinapril. Consequently, angioedema may not always be a class effect of ACE inhibitors.Since the mid-1970s, neoliberal policies have relied on privatization and other tactics to down-size the state, transforming human service organizat
Like
Comment
Share
